News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
25,338 Results
Type
Article (1148)
Company Profile (2)
Press Release (24188)
Section
Business (12155)
Career Advice (59)
Deals (1644)
Drug Delivery (1)
Drug Development (1974)
Employer Resources (2)
FDA (380)
Job Trends (518)
News (15494)
Policy (680)
Tag
Academia (56)
Allergies (4)
Alliances (867)
ALS (2)
Alzheimer's disease (30)
Antibody-drug conjugate (ADC) (10)
Approvals (399)
Artificial intelligence (7)
Autoimmune disease (1)
Bankruptcy (4)
Best Places to Work (427)
BIOSECURE Act (1)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (2)
Brain cancer (1)
Breast cancer (15)
Cancer (137)
Cardiovascular disease (21)
Career advice (41)
CAR-T (8)
CDC (1)
Cell therapy (18)
Clinical research (1885)
Collaboration (21)
Compensation (11)
COVID-19 (38)
CRISPR (3)
C-suite (7)
Cystic fibrosis (1)
Data (242)
Depression (4)
Diabetes (11)
Diagnostics (210)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (4)
Drug pricing (8)
Duchenne muscular dystrophy (4)
Earnings (11645)
Employer resources (2)
Events (2879)
Executive appointments (6)
FDA (572)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (25)
Gene editing (7)
Gene therapy (11)
GLP-1 (28)
Government (72)
Guidances (139)
Healthcare (610)
HIV (3)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (5)
Indications (5)
Infectious disease (46)
Inflammatory bowel disease (2)
Inflation Reduction Act (1)
Influenza (1)
Intellectual property (4)
Interviews (9)
IPO (1211)
IRA (1)
Job creations (111)
Job search strategy (39)
Labor market (3)
Layoffs (9)
Legal (138)
Lung cancer (31)
Lymphoma (12)
Manufacturing (5)
MASH (11)
Medical device (579)
Medtech (582)
Mergers & acquisitions (457)
Metabolic disorders (37)
Multiple sclerosis (6)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (65)
NextGen: Class of 2026 (123)
Non-profit (75)
Obesity (18)
Opinion (7)
Ovarian cancer (1)
Pain (2)
Pancreatic cancer (4)
Parkinson's disease (8)
Patents (4)
Patient recruitment (6)
People (738)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (404)
Phase 2 (802)
Phase 3 (776)
Pipeline (533)
Policy (7)
Postmarket research (76)
Preclinical (139)
Press Release (1)
Prostate cancer (8)
Radiopharmaceuticals (11)
Rare diseases (20)
Real estate (124)
Recruiting (1)
Regulatory (550)
Reports (3)
Research institute (32)
Resumes & cover letters (12)
RSV (3)
Schizophrenia (4)
Series A (2)
Series B (2)
Sickle cell disease (6)
Special edition (1)
Spinal muscular atrophy (10)
Startups (61)
Tariffs (4)
Vaccines (18)
Venture capital (2)
Weight loss (13)
Women's health (4)
Date
Today (2)
Last 7 days (20)
Last 30 days (81)
Last 365 days (1442)
2026 (105)
2025 (1463)
2024 (1605)
2023 (1720)
2022 (1990)
2021 (1982)
2020 (1755)
2019 (1229)
2018 (1066)
2017 (761)
2016 (497)
2015 (835)
2014 (3281)
2013 (3375)
2012 (413)
2011 (488)
2010 (474)
Location
Africa (20)
Arizona (10)
Asia (1564)
Australia (142)
California (551)
Canada (155)
China (36)
Colorado (45)
Connecticut (21)
Delaware (17)
Europe (3672)
Florida (46)
Georgia (13)
Idaho (2)
Illinois (30)
India (1)
Indiana (27)
Japan (14)
Kansas (2)
Kentucky (3)
Louisiana (7)
Maine (4)
Maryland (94)
Massachusetts (358)
Michigan (17)
Minnesota (31)
Missouri (4)
Nevada (8)
New Hampshire (3)
New Jersey (172)
New York (139)
North Carolina (86)
Northern California (282)
Ohio (11)
Pennsylvania (115)
Rhode Island (1)
South America (35)
Southern California (227)
Tennessee (6)
Texas (71)
United States (1891)
Utah (16)
Virginia (2)
Washington State (33)
Wisconsin (4)
25,338 Results for "145".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RECORDATI REPORTS STRONG PRELIMINARY FULL YEAR 2025 RESULTS: REVENUE +11.8%, EBITDA(1) +14.5%, ADJUSTED NET INCOME(2) +14.5%
February 17, 2026
·
15 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET
January 15, 2026
·
5 min read
Press Releases
Revalia Bio Raises $14.5M Seed Round to Launch Human Data Trial Platform and Redefine Drug Development
September 5, 2025
·
4 min read
Press Releases
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
October 28, 2025
·
6 min read
Legal
Jazz Settles for $145M in Anti-Trust Suits Centering on Xyrem Generics
Jazz is being accused of anti-competitive practices regarding its narcolepsy drug, as generic competitors emerge on the market.
April 9, 2025
·
2 min read
·
Tristan Manalac
Business
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa
As BioNTech struggles to establish its footing in a post-pandemic world, the biotech has secured $145 million from the Coalition for Epidemic Preparedness Innovations to expand its mRNA operations in Rwanda.
May 30, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology
Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology.
June 28, 2024
·
4 min read
Genetown
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual Meeting
Merus N.V. announced updated interim clinical data on MCLA-145 monotherapy and in combination with pembrolizumab were presented at the 2024 American Society of Clinical Oncology® Annual Meeting taking place in Chicago May 31-June 4, 2024.
June 2, 2024
·
7 min read
Press Releases
Liquid Biopsy Market Size Surges 14.5% CAGR to Soar $23.94 Billion by 2034
February 20, 2025
·
1 min read
Biotech Bay
Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer
Iovance Biotherapeutics, Inc. announced a clinical program update for LN-145 TIL therapy in non-small lung cancer.
December 27, 2023
·
8 min read
1 of 2,534
Next
